Showing 2321-2340 of 7110 for: Cochrane Systematic Reviews Back
- Fibreoptic phototherapy for neonatal jaundice
Cochrane Systematic Reviews, 26-Oct-2008
Phototherapy is used to treat newborn infants with hyperbilirubinaemia. Fibreoptic phototherapy is a new mode of phototherapy which is reported to lower serum bilirubin (SBR) while minimising disruption of normal infant care.
- Fibrin glue instillation under skin flaps to prevent seroma-related morbidity following breast and axillary surgery
Cochrane Systematic Reviews, 2-Apr-2013
Fibrin glue (FG) combines fibrinogen and thrombin, under the presence of factor XIII and calcium chloride, and produces a 'fibrin clot' as would occur through the natural clotting cascade. FG is thought to close over any small vessels including lymphatics
- Fibrin sealant use for minimising peri-operative allogeneic blood transfusion
Cochrane Systematic Reviews, 12-May-2009
Fibrin sealants (also referred to as biological glue or fibrin tissue adhesives) have gained increasing popularity as interventions to improve peri-operative (intra- and post-operative) haemostasis and diminish the need for allogeneic red cell transfusion
- Fibrin sealants for the prevention of postoperative pancreatic fistula following pancreatic surgery
Cochrane Systematic Reviews, 13-Feb-2016
Postoperative pancreatic fistula is one of the most frequent and potentially life-threatening complications following pancreatic resections. Fibrin sealants are introduced to reduce postoperative pancreatic fistula by some surgeons. However, the use of fi
- Fibrinogen concentrate in bleeding patients
Cochrane Systematic Reviews, 29-Aug-2013
Hypofibrinogenaemia is associated with increased morbidity and mortality, but the optimal treatment level, the use of preemptive treatment and the preferred source of fibrinogen remain disputed. Fibrinogen concentrate is increasingly used and recommended
- Fibrinogen depleting agents for acute ischaemic stroke
Cochrane Systematic Reviews, 31-Oct-2013
Fibrinogen depleting agents reduce fibrinogen in blood plasma, reduce blood viscosity and hence increase blood flow. This may help remove the blood clot blocking the artery and re-establish blood flow to the affected area of the brain after an ischaemic s
- Fibrinolytic agents for peripheral arterial occlusion
Cochrane Systematic Reviews, 18-Dec-2013
Peripheral arterial thrombolysis is used in the management of peripheral arterial ischaemia. Streptokinase was originally used but safety concerns led to a search for other agents. Urokinase and recombinant tissue plasminogen activator (rt-PA) have increa
- Fibrinolytic therapy for intraventricular hemorrhage in adults
Cochrane Systematic Reviews, 24-Aug-2008
Spontaneous or secondary intraventricular hemorrhage is a marker of poor prognosis for hemorrhagic stroke. It can cause hydrocephalus and require ventricular shunt placement, result in permanent neurological deficits or death. Fibrinolytic agents injected
- Financial benefits for child health and well-being in low income or socially disadvantaged families in developed world countries
Cochrane Systematic Reviews, 11-Jul-2012
A strong and consistent relationship has been observed between relative poverty and poor child health and well-being even among rich nations. This review set out to examine evidence that additional monies provided to poor or disadvantaged families may ben
- Financial interventions and movement restrictions for managing the movement of health workers between public and private organizations in low- and middle-income countries
Cochrane Systematic Reviews, 10-Feb-2014
Health workers move between public and private organizations in both urban and rural areas during the course of their career. Depending on the proportion of the population served by public or private organizations in a particular setting, this movement ma
- Finasteride for benign prostatic hyperplasia
Cochrane Systematic Reviews, 17-Dec-2015
Benign prostatic hyperplasia (BPH), a non-malignant enlargement of the prostate in aging men, can cause bothersome urinary symptoms (intermittency, weak stream, straining, urgency, frequency, incomplete emptying). Finasteride, a five-alpha reductase inhib
- First aid glucose administration routes for symptomatic hypoglycaemia
Cochrane Systematic Reviews, 11-Apr-2019
Hypoglycaemia is a common occurrence in people with diabetes but can also result from an imbalance in glucose homeostasis in the absence of diabetes. The best enteral route for glucose administration for suspected hypoglycaemia in a first aid situation is
- First rank symptoms for schizophrenia
Cochrane Systematic Reviews, 7-Jan-2015
Early and accurate diagnosis and treatment of schizophrenia may have long-term advantages for the patient; the longer psychosis goes untreated the more severe the repercussions for relapse and recovery. If the correct diagnosis is not schizophrenia, but a
- First trimester serum tests for Down's syndrome screening
Cochrane Systematic Reviews, 25-Nov-2015
Down's syndrome occurs when a person has three, rather than two copies of chromosome 21; or the specific area of chromosome 21 implicated in causing Down's syndrome. It is the commonest congenital cause of mental disability and also leads to numerous meta
- First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia
Cochrane Systematic Reviews, 19-Jul-2013
Acquired severe aplastic anemia is a rare and potentially fatal disease, which is characterized by hypocellular bone marrow and pancytopenia. The major signs and symptoms are severe infections, bleeding, and exhaustion. First-line allogeneic hematopoietic
- First-line beta-blockers versus other antihypertensive medications for chronic type B aortic dissection
Cochrane Systematic Reviews, 26-Feb-2014
Thoracic aortic dissection (TAD) is a severe and often lethal complication in people with hypertension. Current practice in the treatment of chronic type B aortic dissections is the use of beta-blockers as first-line therapy to decrease aortic wall stress
- First-line chemotherapy in low-risk gestational trophoblastic neoplasia
Cochrane Systematic Reviews, 1-Apr-2015
This is an update of a Cochrane review that was first published in Issue 1, 2009. Gestational trophoblastic neoplasia (GTN) is a rare but curable disease arising in the fetal chorion during pregnancy. Most women with low-risk GTN will be cured by evacuati
- First-line drugs for hypertension
Cochrane Systematic Reviews, 12-May-2009
Sustained elevated blood pressure, unresponsive to lifestyle measures, leads to a critically important clinical question: What class of drug to use first-line? This review answers that question.
- First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension
Cochrane Systematic Reviews, 7-Jan-2015
Renin-angiotensin system (RAS) inhibitors are widely prescribed for treatment of hypertension, especially for diabetic patients on the basis of postulated advantages for the reduction of diabetic nephropathy and cardiovascular morbidity and mortality. Des
- First-line tandem high-dose chemotherapy and autologous stem cell transplantation versus single high-dose chemotherapy and autologous stem cell transplantation in multiple myeloma, a systematic review of controlled studies
Cochrane Systematic Reviews, 14-Aug-2012
Several clinical studies have compared single with tandem (also called double) autologous stem cell transplantation (ASCT) as first-line treatment in patients with symptomatic multiple myeloma (MM), one of the leading indications for ASCT worldwide.
